Source:http://linkedlifedata.com/resource/pubmed/id/11832363
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2002-2-8
|
pubmed:abstractText |
We investigated the effects of 6 mo of near-physiological testosterone administration to older men on skeletal muscle function and muscle protein metabolism. Twelve older men (> or =60 yr) with serum total testosterone concentrations <17 nmol/l (480 ng/dl) were randomly assigned in double-blind manner to receive either placebo (n = 5) or testosterone enanthate (TE; n = 7) injections. Weekly intramuscular injections were given for the 1st mo to establish increased blood testosterone concentrations at 1 mo and then changed to biweekly injections until the 6-mo time point. TE doses were adjusted to maintain nadir serum testosterone concentrations between 17 and 28 nmol/l. Lean body mass (LBM), muscle volume, prostate size, and urinary flow were measured at baseline and at 6 mo. Protein expression of androgen receptor (AR) and insulin-like growth factor I, along with muscle strength and muscle protein metabolism, were measured at baseline and at 1 and 6 mo of treatment. Hematological parameters were followed monthly throughout the study. Older men receiving testosterone increased total and leg LBM, muscle volume, and leg and arm muscle strength after 6 mo. LBM accretion resulted from an increase in muscle protein net balance, due to a decrease in muscle protein breakdown. TE treatment increased expression of AR protein at 1 mo, but expression returned to pre-TE treatment levels by 6 mo. IGF-I protein expression increased at 1 mo and remained increased throughout TE administration. We conclude that physiological and near-physiological increases of testosterone in older men will increase muscle protein anabolism and muscle strength.
|
pubmed:grant | |
pubmed:keyword | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0193-1849
|
pubmed:author |
pubmed-author:AchacosaAlisonA,
pubmed-author:FerrandoArny AAA,
pubmed-author:GilkisonCharlesC,
pubmed-author:JiangJieJ,
pubmed-author:LiebermanSteven ASA,
pubmed-author:Sheffield-MooreMelindaM,
pubmed-author:TiptonKevinK,
pubmed-author:UrbanRandall JRJ,
pubmed-author:WolfeRobert RRR,
pubmed-author:YeckelCatherine WCW
|
pubmed:issnType |
Print
|
pubmed:volume |
282
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
E601-7
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11832363-Aged,
pubmed-meshheading:11832363-Aged, 80 and over,
pubmed-meshheading:11832363-Blotting, Western,
pubmed-meshheading:11832363-Body Composition,
pubmed-meshheading:11832363-Diuresis,
pubmed-meshheading:11832363-Double-Blind Method,
pubmed-meshheading:11832363-Humans,
pubmed-meshheading:11832363-Injections, Intramuscular,
pubmed-meshheading:11832363-Insulin-Like Growth Factor I,
pubmed-meshheading:11832363-Male,
pubmed-meshheading:11832363-Middle Aged,
pubmed-meshheading:11832363-Muscle, Skeletal,
pubmed-meshheading:11832363-Placebos,
pubmed-meshheading:11832363-Prostate,
pubmed-meshheading:11832363-Receptors, Androgen,
pubmed-meshheading:11832363-Testosterone,
pubmed-meshheading:11832363-Treatment Outcome
|
pubmed:year |
2002
|
pubmed:articleTitle |
Testosterone administration to older men improves muscle function: molecular and physiological mechanisms.
|
pubmed:affiliation |
Department of Surgery, The University of Texas Medical Branch, Galveston, Texas 77550, USA. aferrand@utmb.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|